LYCOS RETRIEVER 
Onyx: Onyx Pharmaceuticals
built 237 days ago
EMERYVILLE, Calif., Nov 06, 2007 /PRNewswire-FirstCall via COMTEX/ -- Onyx Pharmaceuticals, Inc. (ONXX) today reported its financial results for the three and nine months ended September 30, 2007. Onyx reported net income of $555,000, or $0.01 per share, for the third quarter of 2007 compared to a net loss of $20.1 million, or $0.49 per share, in the same period in the prior year.
Source:
EMERYVILLE, Calif., Oct. 3 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, (News) Inc. today announced that it will present at the Biotechnology Industry Organization Investor Forum on Wednesday, October 10 at 11:15 a.m. Pacific Time. Interested parties may access a live webcast of the presentation at:
Source:
Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including Nexavar(R) (sorafenib) tablets with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's website at http://www.onyx-pharm.com/.
Source:
Ms. Kim's industry credentials include senior positions at Affymax, Onyx Pharmaceuticals, Protein Design Labs and Chiron Corporation. At Affymax, she served as Chief Business Officer where she created and implemented a new business model and was responsible for portfolio prioritization, licensing and capital formation. At Onyx, Ms. Kim established and managed corporate collaborations and had oversight for project management, strategic marketing and investor relations. At Protein Design Labs, she originated the company's marketing and research and development project management functions and was responsible for strategic marketing. At Chiron, she led the global strategic marketing function for Chiron's therapeutics and vaccines businesses including new product launches and established multiple external collaborations including licensing, co-development and joint venture transactions. Ms. Kim most recently served as Chief Program Officer for the Gordon and Betty Moore Foundation where she successfully developed initiatives to transform healthcare delivery practices in acute care hospitals.
Source:
EMERYVILLE, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. today announced that it will present at the Biotechnology Industry Organization (BIO) CEO & Investor conference on Tuesday, February 14, at 11:30 a.m. Eastern Time. Interested parties may access a live webcast of the presentation at:
Source:
EMERYVILLE, Calif., Jan. 2 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX - News) today announced that it will present at the JPMorgan Healthcare Conference on Monday, January 7, at 11:30 a.m. Pacific Time. Interested parties may access a live webcast of the presentation at:
Source:
MORE ABOUT
Onyx Pharmaceuticals